AcelRx Pharmaceuticals’ $32.5 Million Acquisition of Lowell Therapeutics

Sonia Carcano North America Legal Chronicle
Tagged:

Burns & Levinson LLP represented Lowell Therapeutics, Inc. in its sale to AcelRx Pharmaceuticals. AcelRx Pharmaceuticals (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Sonia Carcano

Author: Sonia Carcano

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here